INSIDER · CIK 2084407
Lawlor Sally Bridget
Chief Financial Officer at Quoin Pharmaceuticals, Ltd. (QNRX)
↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$50KBought on the market
$0.00Sold on the market
1Companies
Sep 1, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 202621:39 | Aug 31, 2026 | QNRXQuoin Pharmaceuticals, Ltd. | Chief Financial Officer | P · Buy | $4.88 | +10,244 | 10,684 | +2328% | +$50K | -20.3% | -15.0% |